VJHemOnc is committed to improving our service to you

COMy 2019 | The case for IMiDs in relapsed MM

VJHemOnc is committed to improving our service to you

Meral Beksac

Meral Beksac, MD, from Ankara University, Ankara, Turkey, discusses the case for using immunomodulatory drugs (IMiDs) in the treatment of relapsed multiple myeloma. This interview took place at the Controversies in Multiple Myeloma (COMy) 2019 World Congress in Paris, France.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter